Review



imaging system  (Revvity)


Bioz Verified Symbol Revvity is a verified supplier
Bioz Manufacturer Symbol Revvity manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Revvity imaging system
    Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 38887 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/IVIS+optical+imaging+platform/pm43043227-390-10-12
    Average 96 stars, based on 38887 article reviews
    imaging system - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Radioactivity:

    Article Title: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice.
    Article Snippet: .. Depending on the amount of radioactivity injected, the scanning time for SPECT imaging is 10–50 min per animal41–43 and PET imaging is 15–60 min per animal44–47.To coregister detailed anatomical localization with molecular information, commercial small animal SPECT (e.g., nanoScan SPECT/CT, Mediso), PET (e.g., nanoScan PET/CT, Mediso) and optical (e.g., IVIS SpectrumCT, PerkinElmer) imaging scanners usually have an integrated X-ray CT inside the same imaging gantry or platform. ..

    Injection:

    Article Title: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice.
    Article Snippet: .. Depending on the amount of radioactivity injected, the scanning time for SPECT imaging is 10–50 min per animal41–43 and PET imaging is 15–60 min per animal44–47.To coregister detailed anatomical localization with molecular information, commercial small animal SPECT (e.g., nanoScan SPECT/CT, Mediso), PET (e.g., nanoScan PET/CT, Mediso) and optical (e.g., IVIS SpectrumCT, PerkinElmer) imaging scanners usually have an integrated X-ray CT inside the same imaging gantry or platform. ..

    Single Photon Emission Computed Tomography:

    Article Title: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice.
    Article Snippet: .. Depending on the amount of radioactivity injected, the scanning time for SPECT imaging is 10–50 min per animal41–43 and PET imaging is 15–60 min per animal44–47.To coregister detailed anatomical localization with molecular information, commercial small animal SPECT (e.g., nanoScan SPECT/CT, Mediso), PET (e.g., nanoScan PET/CT, Mediso) and optical (e.g., IVIS SpectrumCT, PerkinElmer) imaging scanners usually have an integrated X-ray CT inside the same imaging gantry or platform. ..

    Imaging:

    Article Title: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice.
    Article Snippet: .. Depending on the amount of radioactivity injected, the scanning time for SPECT imaging is 10–50 min per animal41–43 and PET imaging is 15–60 min per animal44–47.To coregister detailed anatomical localization with molecular information, commercial small animal SPECT (e.g., nanoScan SPECT/CT, Mediso), PET (e.g., nanoScan PET/CT, Mediso) and optical (e.g., IVIS SpectrumCT, PerkinElmer) imaging scanners usually have an integrated X-ray CT inside the same imaging gantry or platform. ..

    Positron Emission Tomography:

    Article Title: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice.
    Article Snippet: .. Depending on the amount of radioactivity injected, the scanning time for SPECT imaging is 10–50 min per animal41–43 and PET imaging is 15–60 min per animal44–47.To coregister detailed anatomical localization with molecular information, commercial small animal SPECT (e.g., nanoScan SPECT/CT, Mediso), PET (e.g., nanoScan PET/CT, Mediso) and optical (e.g., IVIS SpectrumCT, PerkinElmer) imaging scanners usually have an integrated X-ray CT inside the same imaging gantry or platform. ..



    Similar Products

    96
    Revvity imaging system
    Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/IVIS+optical+imaging+platform/pm43043227-390-10-12
    Average 96 stars, based on 1 article reviews
    imaging system - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    90
    Carl Zeiss wide-angle optical coherence tomography angiography
    Wide Angle Optical Coherence Tomography Angiography, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/cirrus+hd+oct+%EB%B9%9B%EA%B0%84%EC%84%AD%EB%8B%A8%EC%B8%B5%EC%B4%AC%EC%98%81%EA%B8%B0+%EC%8A%A4%ED%8E%99%ED%8A%B8%EB%9F%BC%EB%8F%84%EB%A9%94%EC%9D%B8/nct03666052-49-46-54
    Average 90 stars, based on 1 article reviews
    wide-angle optical coherence tomography angiography - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Tecan Systems microplate reader
    Microplate Reader, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/Infinite+200+Pro+M+Plex%2C+Multi-mode+microplate+reader%2C+Monochromator+optics/pm43036641-68-36-41
    Average 96 stars, based on 1 article reviews
    microplate reader - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Revvity ivis spectrum
    Ivis Spectrum, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/IVIS+optical+imaging+platform/pmc13770896-90-14-16
    Average 96 stars, based on 1 article reviews
    ivis spectrum - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Revvity luciferin substrate
    CD8a‐NVE@KRN2 combined with anti‐PD‐1 antibody suppresses tumor formation in CC models. Note: (A) Schematic illustration of establishing subcutaneous and orthotopic transplantation tumor models created with BioRender. (B) Measurement of tumor volume in the subcutaneous model using calipers. (C) Bioluminescence imaging of tumor growth in the orthotopic model using the <t>IVIS‐200</t> system. Representative images are shown for PBS, CD8a‐NVE@KRN2, and CD8a‐NVE@KRN2 + anti‐PD‐1; the adjacent total‐flux plot includes all five treatment groups. Between‐group comparisons are based on total flux. (D) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. (E) Tumor weight measurement in the orthotopic model. (F‐G) ELISA quantification of IL‐18 levels in tumor tissues from subcutaneous and orthotopic models. (H) Western blot analysis of GSDMB‐N and GSDMB‐FL protein expression in tumors from the orthotopic model. Low‐, medium‐, and high‐dose anti‐PD‐1 combination groups were included where indicated. Each group consisted of 6 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Luciferin Substrate, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/IVIS+optical+imaging+platform/pmc13770899-64-10-25
    Average 96 stars, based on 1 article reviews
    luciferin substrate - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Olympus optical microscope
    CD8a‐NVE@KRN2 combined with anti‐PD‐1 antibody suppresses tumor formation in CC models. Note: (A) Schematic illustration of establishing subcutaneous and orthotopic transplantation tumor models created with BioRender. (B) Measurement of tumor volume in the subcutaneous model using calipers. (C) Bioluminescence imaging of tumor growth in the orthotopic model using the <t>IVIS‐200</t> system. Representative images are shown for PBS, CD8a‐NVE@KRN2, and CD8a‐NVE@KRN2 + anti‐PD‐1; the adjacent total‐flux plot includes all five treatment groups. Between‐group comparisons are based on total flux. (D) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. (E) Tumor weight measurement in the orthotopic model. (F‐G) ELISA quantification of IL‐18 levels in tumor tissues from subcutaneous and orthotopic models. (H) Western blot analysis of GSDMB‐N and GSDMB‐FL protein expression in tumors from the orthotopic model. Low‐, medium‐, and high‐dose anti‐PD‐1 combination groups were included where indicated. Each group consisted of 6 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Optical Microscope, supplied by Olympus, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/BX43+Manual+System+Microscope/pm42854948-81-7-10
    Average 96 stars, based on 1 article reviews
    optical microscope - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Revvity ivis lumina series iii in vivo imaging system
    CD8a‐NVE@KRN2 combined with anti‐PD‐1 antibody suppresses tumor formation in CC models. Note: (A) Schematic illustration of establishing subcutaneous and orthotopic transplantation tumor models created with BioRender. (B) Measurement of tumor volume in the subcutaneous model using calipers. (C) Bioluminescence imaging of tumor growth in the orthotopic model using the <t>IVIS‐200</t> system. Representative images are shown for PBS, CD8a‐NVE@KRN2, and CD8a‐NVE@KRN2 + anti‐PD‐1; the adjacent total‐flux plot includes all five treatment groups. Between‐group comparisons are based on total flux. (D) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. (E) Tumor weight measurement in the orthotopic model. (F‐G) ELISA quantification of IL‐18 levels in tumor tissues from subcutaneous and orthotopic models. (H) Western blot analysis of GSDMB‐N and GSDMB‐FL protein expression in tumors from the orthotopic model. Low‐, medium‐, and high‐dose anti‐PD‐1 combination groups were included where indicated. Each group consisted of 6 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Ivis Lumina Series Iii In Vivo Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/optical/IVIS+optical+imaging+platform/pmc13763943-343-33-41
    Average 96 stars, based on 1 article reviews
    ivis lumina series iii in vivo imaging system - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    CD8a‐NVE@KRN2 combined with anti‐PD‐1 antibody suppresses tumor formation in CC models. Note: (A) Schematic illustration of establishing subcutaneous and orthotopic transplantation tumor models created with BioRender. (B) Measurement of tumor volume in the subcutaneous model using calipers. (C) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. Representative images are shown for PBS, CD8a‐NVE@KRN2, and CD8a‐NVE@KRN2 + anti‐PD‐1; the adjacent total‐flux plot includes all five treatment groups. Between‐group comparisons are based on total flux. (D) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. (E) Tumor weight measurement in the orthotopic model. (F‐G) ELISA quantification of IL‐18 levels in tumor tissues from subcutaneous and orthotopic models. (H) Western blot analysis of GSDMB‐N and GSDMB‐FL protein expression in tumors from the orthotopic model. Low‐, medium‐, and high‐dose anti‐PD‐1 combination groups were included where indicated. Each group consisted of 6 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Journal of Extracellular Vesicles

    Article Title: CD8a‐Functionalized Red Blood Cell Membrane Nanovesicles Delivering KRN2 for Coordinated T Cell Reinvigoration and Macrophage Metabolic Reprogramming in Cardia Cancer

    doi: 10.1002/jev2.70384

    Figure Lengend Snippet: CD8a‐NVE@KRN2 combined with anti‐PD‐1 antibody suppresses tumor formation in CC models. Note: (A) Schematic illustration of establishing subcutaneous and orthotopic transplantation tumor models created with BioRender. (B) Measurement of tumor volume in the subcutaneous model using calipers. (C) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. Representative images are shown for PBS, CD8a‐NVE@KRN2, and CD8a‐NVE@KRN2 + anti‐PD‐1; the adjacent total‐flux plot includes all five treatment groups. Between‐group comparisons are based on total flux. (D) Bioluminescence imaging of tumor growth in the orthotopic model using the IVIS‐200 system. (E) Tumor weight measurement in the orthotopic model. (F‐G) ELISA quantification of IL‐18 levels in tumor tissues from subcutaneous and orthotopic models. (H) Western blot analysis of GSDMB‐N and GSDMB‐FL protein expression in tumors from the orthotopic model. Low‐, medium‐, and high‐dose anti‐PD‐1 combination groups were included where indicated. Each group consisted of 6 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: To monitor tumour growth, mice were intraperitoneally injected weekly with luciferin substrate (150 mg/kg) and imaged 10 min later using the IVIS‐200 bioluminescence imaging system (Perkin Elmer, USA).

    Techniques: Transplantation Assay, Tumor Models, Bioluminescence Imaging, Enzyme-linked Immunosorbent Assay, Western Blot, Analysis, Expressing